DocNexus

Proud that DocNexus is a Platinum Sponsor at the Reuters Pharma Conference! Stop by Booth 33 to learn more about how DocNexus is shaping the future of Healthcare AI Search. Whether you're looking to streamline Medical insights, Optimize HCP engagement, or Unlock Commercial Real-time Analytics, or leverage AI-Powered Search Engine we’d love to connect. Our team will be in Philly next week—let’s talk about what’s next for AI for life sciences! ?? Reuters Pharma USA | Booth 33 ?? See you there! #Pharma #Healthcare #AISearch #DocNexus #ReutersPharma #MedicalAI

We are thrilled to announce that two companies have joined the Mayo Clinic Platform_Accelerate program: DocNexus and Survon! As part of our 30-week health tech accelerator, these companies will have access to rich, de-identified data sets and mentorship from world-class experts. Learn more about these innovative companies: DocNexus DocNexus aims to transform healthcare through the intelligent use of electronic medical records. By automating critical aspects of clinical workflows, we make medical records more actionable and efficient for healthcare providers. Our AI-driven solutions are designed to enhance the effectiveness of clinical decision-making, ultimately improving patient outcomes. DocNexus is committed to pioneering innovations that simplify and optimize the healthcare delivery process. Survon, Inc Survon, an oncology AI start-up born from Harvard's innovation ecosystem, is at the forefront of transforming cancer care. By harnessing the power of advanced imaging, cutting-edge artificial intelligence, and sophisticated predictive analytics, we are reshaping the landscape of oncology. Our mission is to empower healthcare professionals and patients with AI-driven solutions that enhance early cancer detection, optimize treatment strategies, improve patient outcomes, as well as monitor and predict cancer recurrence. By combining world-class expertise in oncology, data science, and AI, Survon is ushering in a new era of precision medicine. Want to follow their journey? Subscribe to the Accelerate monthly newsletter: https://lnkd.in/g96DtAtS #ai #healthcare #startups #healthtech #mayoclinicplatform

?? At DocNexus, we're excited to announce the launch of DocNexus Hospital & Health System Navigator! This powerful solution provides sales and marketing teams with deep, real-time insights into 589 health systems and 7,200 hospitals across the U.S. ?? Key features include: -Targeted Opportunity Identification: Segment health systems and hospitals by procedure volumes, payer mix, and diagnostic codes to find growing demand. -Personalized Strategies: Analyze referral patterns and prescription trends to tailor outreach -Real-Time Market Monitoring: Access up-to-date news, notes, and trends to stay ahead of market shifts. -Payer Mix Insights: Understand financial dynamics and reimbursement challenges to better position products. Excited to see how this will help commercial and marketing teams elevate performance and boost HCO engagement! https://lnkd.in/gsEkWq-d #DocNexus #healthsystems #launch

DocNexus provides value across the industry.. by enabling our customers with their activities... R&D trials: Selecting suitable PI & Site candidates for clinical trials through advanced analytics and AI. ?? Medical affairs: Educating HCPs on the latest medical advancements through comprehensive scientific expertise. ?? Commercial strategies: Optimising sales team efforts through sophisticated territory alignment and segmentation strategies. ?? Compliance: Adhering to data privacy regulations ?? Marketing initiatives: Delivering personalized messaging through omnichannel marketing strategies to engage HCPs to reach their patients effectively. ?? At DocNexus, we harness the power of data to revolutionise pharmaceutical processes, relationships, and results. Our platform use cases are expansive.Helping our industry partners to define and execute on clear medical and commercial objectives, ensuring high-quality data integration, and aligning data models with business needs. ??.. Get in Touch

?? Celebrating Leaders in Type 2 Diabetes Research and Care ?? The CDC estimates that more than 37 million Americans have diabetes, and 90–95% of those cases are type 2 diabetes.?This is about 1 in 10 people in the United States. At DocNexus we are excited to recognize the leading experts dedicated to advancing our understanding and treatment of this widespread condition. Here are some of the top professionals whose work is making a significant impact: ?? George Bakris, MD, F.A.H.A, F.A.S.N. - Professor of Medicine and Director of the American Heart Association's Comprehensive Hypertension Center at The The University of Chicago Pritzker School of Medicine. ?? Leonard Egede, MD, MS, FACP - Chief of Division of General Internal Medicine and Director of the Center for Advancing Population Science (CAPS), and Inaugural Milwaukee Community Chair in Health Equity Research at the Medical College of Wisconsin. ?? Guillermo Umpierrez - Professor at Emory University School of Medicine and Director of Clinical Research Network and the Diabetes and Endocrinology Section at Grady Memorial Hospital. 4?? Richard Pratley - Medical Director at the AdventHealth Diabetes Institute and Senior Investigator, Diabetes Program Lead at the Florida Hospital Translational Research Institute. 5?? Rich Bergenstal - Executive Director of the Park Nicollet International Diabetes Center and Clinical Professor in the Department of Medicine at the University of Minnesota. 6?? Ildiko Lingvay - Professor of Medicine at University of Texas Southwestern Medical Center at Dallas. 7?? Vanita Aroda - Director of Diabetes Clinical Research at Brigham and Women's Hospital and Associate Professor of Medicine at Harvard Medical School. 8?? Anne Peters - Professor of Medicine at the Keck School of Medicine of the University of Southern California and Director of the USC Clinical Diabetes Programs. 9?? Deborah J. Wexler - Chief of the Massachusetts General Hospital Diabetes Unit and Associate Professor of Medicine at Harvard Medical School . ?? Gary Meininger - Executive Vice President and Chief Medical Officer at Sana Biotechnology, Inc.. Join us in honoring these exceptional individuals who continue to lead the charge against Type 2 Diabetes, improving countless lives through their dedication and expertise. #Type2Diabetes #HealthcareHeroes #MedicalExcellence #DiabetesCare

?? Parkinson's disease ranks as the second most prevalent neurodegenerative disorder, following Alzheimer's disease. In the United States, nearly one million individuals live with Parkinson's, with over 90,000 new cases diagnosed annually. ?? We're proud to spotlight some of the foremost experts dedicated to advancing our understanding and treatment of Parkinson's Disease. Their pioneering work is not just advancing medical science but also offering hope to millions affected worldwide. ?? Dr. Alberto Espay - Professor at the University of Cincinnati and Co-Founder of Regain Therapeutics ?? Dr. Michael S Okun - Executive Director of the Norman Fixel Institute for Neurological Diseases and Chair of Neurology at University of Florida Health ?? Dr. Rohit Dhall - Serving as Professor and Chair of Neurology at UAMS - University of Arkansas for Medical Sciences 4?? Dr. Kumar Narayanan - An Associate Professor at University of Iowa Health Care 5?? Dr. Mustafa Siddiqui, MD, FAAN - Professor of Neurology & Neurosurgery and Medical Director of Deep Brain Stimulation (DBS) at Atrium Health Wake Forest Baptist. 6?? Dr. Pinky Agarwal - Neurologist at Evergreen Healthcare Group 7?? Dr. Rajesh Pahwa - Professor of Neurology and Chief of the Parkinson's and Movement Disorder Division at the University of Kansas Medical Center 8?? Dr. Robert Hauser - Professor of Neurology and Director of the Parkinson's Disease and Movement Disorders Center at the University of South Florida 9?? Dr. Stuart Isaacson, MD - Co-Director at The Institute for Neurodegenerative Diseases (IND) ?? Dr. Andrew Siderowf - Professor of Neurology and Chief of the Movement Disorders Division at the University of Pennsylvania Perelman School of Medicine ?? Join us in honoring these incredible professionals for their dedication to combating Parkinson’s Disease. Their contributions are not just advancing medical science but are also crucial in improving the lives of those affected. ?????? ?? ?? ?? ?????? THE MICHAEL J FOX FOUNDATION FOR PARKINSON #ParkinsonsAwareness #Neurology #HealthcareHeroes #MedicalExcellence

ASCO!!! callout for attendees in my pharma Network . Our CEO Mahek Chhatrapati will be there this year and would love to connect and explore how DocNexus can support you in bringing life saving medicines to Oncology patients faster! Please reach out to him.

Migraines are one of the most common disorders worldwide. Estimates show it may affect up to 148 million people globally and more than 37 million people in the US alone. Today, we celebrate the outstanding contributions of leading migraine specialists. Their dedication to advancing migraine treatment and understanding has brought hope and relief to countless patients. Here are the top doctors making significant strides in helping to fight this chronic neurological disorder: ?? Andrew Blumenfeld - Director, The San Diego Headache Center and The Los Angeles Headache Center. ?? Dr. Sheena Aurora - Vice President of Neurology at C2N Diagnostics and Adjunct Professor at Stanford University School of Medicine. ?? John Rothrock - Director of APP Training and Professor of Neurology, Inova Health and the University of Virginia School of Medicine. 4?? Stewart Tepper - Professor of Neurology, Geisel School of Medicine at Dartmouth. 5?? Todd Schwedt, MD - Professor of Neurology at Mayo Clinic, President Elect of the American Headache Society. 6?? Amaal Starling, MD, FAHS, FAAN - Associate Professor of Neurology at Mayo Clinic. 7?? Sait Ashina - Assistant Professor of Neurology and Anesthesia at Harvard Medical School. 8?? Robert Cowan - Director, Stanford Headache Clinic. 9?? Mia Minen - Director of Headache Services, NYU Langone Health. ?? Peter McAllister, M.D., FAAN - CMO at New England Institute for Clinical Research and Ki Clinical Research. Join us in recognizing these incredible professionals for their commitment to improving the lives of those affected by migraines. To learn more or schedule a demo please visit us at www.docnexus.ai. #MigraineAwareness #headache #Neurology #HealthcareHeroes #MedicalExcellence #AI #LifeScience #KOL #KeyOpinionLeaders #docnexus

??Hey everyone! I'm thrilled to announce that I'll be attending ASCO this year! At DocNexus, we're proud to introduce our advanced oncology data platform, enabling effortless navigation through millions of data points, including publications, clinical trials, payments, RWE data, and social media data, in just seconds. We can help to identify Key Oncology HCP/KOLs, products, pharmaceutical firms, and healthcare systems for valuable market intelligence. ?? I can't wait to network with old friends and make new connections, sharing insights and ideas that will shape the future of cancer care. Whether you're a researcher, clinician, or industry leader, I'd love to connect and exchange thoughts on the latest developments in oncology. ?? Drop me a message or grab time on my calendar if you'd like to meet up during ASCO. Let's collaborate, inspire, and make a difference together! See you there! ?? #ASCO2024 #Oncology #CancerResearch Calendar: https://lnkd.in/g9RNKUcS

?? Heading to ASCO this weekend? ??? DocNexus has your back! Whether you're presenting groundbreaking research or eager to explore the latest advancements in oncology, we're here to help you make the most out of your congress experience. ???? Our platform offers a suite of tools designed to streamline your preparation, from organizing schedules and accessing scientific literature to networking with fellow attendees and staying updated on key sessions. With DocNexus, you can navigate ASCO with confidence and efficiency. ???? To all our Pharma friends and colleagues attending ASCO, let's connect and collaborate! ?? reach out to Mahek Chhatrapati and schedule a meeting. Together, we can drive innovation and make a difference in cancer care. ????? #ASCO #Oncology #Innovation #Docnexus ??